Women's Health Issues
Volume 14, Issue 3 , Pages 71-74 , May 2004

Women’s cognitive health: postmenopausal dementia and the women's health initiative memory study

  • Karen Potvin Klein, MA

      Affiliations

    • Women's Health Center of Excellence, Wake Forest University School of Medicine, Winston-Salem, NC, USA
    • Corresponding Author InformationCorrespondence to: Karen Potvin Klein, MA, Women's Health Center of Excellence, Wake Forest University School of Medicine, 2000 West First Street, Suite 101, Winston-Salem, North Carolina 27104, USA phone:336-713-4704;fax:336-713-4228.
    • ,
  • Stephen R. Rapp, PhD

      Affiliations

    • Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA

Received 2 February 2004 ,Revised 16 March 2004 ,Accepted 4 May 2004.

References 

  1. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. Journal of the American Medical Association. 1993;269:2637–2641
  2. Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology. 2003;61:1179–1184
  3. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk (A meta-analysis). Obstetrics and Gynecology. 1995;85:304–313
  4. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population (Prevalence estimates using the 2000 census). Archives of Neurology. 2003;60:1119–1122
  5. Hogervorst, E., Yaffe, K., Richards, M., & Huppert, F. (2002). Hormone replacement therapy for cognitive function in postmenopausal women. The Cochrane Database of Systematic Reviews. Oxford, England: Update Software
  6. Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke. 2003;34:335–337
  7. Kawas C, Resnick SM, Morrison A, Brookmeyer R, Corrada M, Zonderman A, et al.  A prospective study of estrogen replacement therapy and the risk of developing Alzheimer disease (The Baltimore Longitudinal Study on Aging). Neurology. 1997;48:1517–1521
  8. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, et al.  Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study (Part 1). Archives of Neurology. 2003;60:1385–1389
  9. Maki PM, Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiology of Aging. 2000;21:373–383
  10. Mulnard RA, Cotman CW, Kawas C, van Dyxk CH, Sano M, Doody R, et al.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. Journal of the American Medical Association. 2000;283:1007–1015
  11. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement (Scientific review). Journal of the American Medical Association. 2002;288:872–881
  12. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS) Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS) . Pathological correlates of late-onset dementia in a multicentre community-based population in England and Wales. Lancet. 2001;347:169–175
  13. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer disease in women. American Journal of Epidemiology. 1994;140:256–261
  14. Payami H, Montee K, Grimslid H, Shattuc S, Kaye J. Increased risk of familial late-onset Alzheimer's disease in women. Neurology. 1996;46:126–129
  15. Phillips S, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 1991;17:485–495
  16. Rapp S, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, et al.  The effect of estrogen with progestin treatment on global cognitive function in postmenopausal women (Results from the Women's Health Initiative Memory Study). Journal of the American Medical Association. 2003;289:2663–2672
  17. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study (A randomized controlled trial). Journal of the American Medical Association. 2003;289:2651–2662
  18. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease (The Nun Study). Journal of the American Medical Association. 1997;277:813–817
  19. Women's Health Initiative Steering Committee Women's Health Initiative Steering Committee . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. Journal of the American Medical Association. 2004;291:1701–1712
  20. Writing Group for the Women's Health Initiative Investigators Writing Group for the Women's Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women (Principal results from the Women's Health Initiative randomized controlled trial). Journal of the American Medical Association. 2002;288:321–333
  21. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women (Effects on cognitive function and dementia). Journal of the American Medical Association. 1998;279:688–695
  22. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, et al. Hormone replacement therapy and the incidence of Alzheimer disease in older women (The Cache County Study). Journal of the American Medical Association. 2002;288:2123–2129

☆ The Women's Health Initiative Memory Study is funded in part by Wyeth Pharmaceuticals. The Women's Health Initiative is funded by the National Heart, Lung and Blood Institute, National Institutes of Health.

PII: S1049-3867(04)00039-8

doi: 10.1016/j.whi.2004.05.001

Women's Health Issues
Volume 14, Issue 3 , Pages 71-74 , May 2004

Article Tools